Literature DB >> 16806500

Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters.

David-Axel Laplaud1, Laureline Berthelot, Patrick Miqueu, Kasia Bourcier, Julien Moynard, Yannick Oudinet, Marina Guillet, Catherine Ruiz, Neal Oden, Sophie Brouard, Charles R G Guttmann, Howard L Weiner, Samia J Khoury, Jean-Paul Soulillou.   

Abstract

A significant skewing of the peripheral T cell repertoire has been shown in relapsing-remitting multiple sclerosis (MS). Most of the studies already performed in this field are cross-sectional and therefore, little is known of the T cell repertoire evolution over time in MS and the correlation of T cell repertoire variation with clinical and MRI parameters. This study was performed on serially harvested frozen PBMC from nine untreated MS patients (27 samples) and 14 healthy individuals. The blood T cell repertoire of each patient was analysed at the complementarity determining region 3 (CDR3) level and compared with a monthly MRI scan performed over a six month period with assessment of T2 lesion load and gadolinium enhancing lesions. A highly significant blood T cell repertoire skewing was observed in MS patients as compared with healthy controls (p<0.01). In addition, the number of altered Vbeta families correlated significantly with both the T2 lesion volume and the number of gadolinium enhancing lesions as assessed by MRI (Spearman correlation tests, r=0.51 and r=0.44, p<0.01 and p<0.05 respectively). Furthermore, the variation of the number of altered Vbeta families over time also correlated with the appearance of new gadolinium enhancing lesions (r=0.36, p=0.05). These findings which need confirmation on larger serial cohorts, suggest an association between the magnitude of TCRBV CDR3 length distribution alterations in the peripheral blood of MS patients and the disease process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806500     DOI: 10.1016/j.jneuroim.2006.05.006

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

Review 1.  Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.

Authors:  Lennart T Mars; Philippe Saikali; Roland S Liblau; Nathalie Arbour
Journal:  Biochim Biophys Acta       Date:  2010-07-15

2.  Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis.

Authors:  Marion Salou; Alexandra Garcia; Laure Michel; Anne Gainche-Salmon; Delphine Loussouarn; Bryan Nicol; Flora Guillot; Philippe Hulin; Steven Nedellec; Daniel Baron; Gérard Ramstein; Jean-Paul Soulillou; Sophie Brouard; Arnaud B Nicot; Nicolas Degauque; David A Laplaud
Journal:  Ann Clin Transl Neurol       Date:  2015-04-28       Impact factor: 4.511

3.  Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis.

Authors:  Rohit Bakshi; Ada Yeste; Bonny Patel; Shahamat Tauhid; Subhash Tummala; Roya Rahbari; Renxin Chu; Keren Regev; Pia Kivisäkk; Howard L Weiner; Francisco J Quintana
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-01-27

4.  Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy.

Authors:  Diego Bertoli; Alessandra Sottini; Ruggero Capra; Cristina Scarpazza; Roberto Bresciani; Luigi D Notarangelo; Luisa Imberti
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

Review 5.  Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation.

Authors:  Nicolas Degauque; Sophie Brouard; Jean-Paul Soulillou
Journal:  Front Immunol       Date:  2016-03-24       Impact factor: 7.561

Review 6.  Involvement of CD8(+) T Cells in Multiple Sclerosis.

Authors:  Marion Salou; Bryan Nicol; Alexandra Garcia; David-Axel Laplaud
Journal:  Front Immunol       Date:  2015-11-26       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.